D. E. Shaw & Co., Inc. Jounce Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.8 - $7.67 $146,893 - $402,383	52,462 New	52,462 $159,000
Q1 2022 May 16, 2022	SELL	$6.01 - $8.54 $413,343 - $587,347	-68,776 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.11 - $9.64 $244,498 - $331,500	34,388 Added 100.0%	68,776 $574,000
Q3 2021 Nov 15, 2021	SELL	$5.04 - $8.73 $224,456 - $388,790	-44,535 Reduced 56.43%	34,388 $256,000
Q2 2021 Aug 16, 2021	BUY	$6.58 - $10.66 $519,313 - $841,319	78,923 New	78,923 $537,000
Q3 2020 Nov 16, 2020	SELL	$4.58 - $10.95 $111,600 - $266,818	-24,367 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.17 - $7.58 $101,610 - $184,701	24,367 New	24,367 $168,000
Q1 2020 May 15, 2020	SELL	$2.91 - $8.7 $99,137 - $296,391	-34,068 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.81 - $9.21 $373,645 - $1.22 Million	-132,970 Reduced 79.6%	34,068 $298,000
Q3 2019 Nov 14, 2019	BUY	$3.33 - $4.93 $111,871 - $165,623	33,595 Added 25.18%	167,038 $557,000
Q2 2019 Aug 14, 2019	SELL	$4.3 - $6.73 $173,569 - $271,656	-40,365 Reduced 23.22%	133,443 $660,000
Q1 2019 May 15, 2019	BUY	$3.43 - $6.87 $274,509 - $549,819	80,032 Added 85.34%	173,808 $1.08 Million
Q4 2018 Feb 14, 2019	BUY	$2.69 - $6.71 $66,098 - $164,878	24,572 Added 35.51%	93,776 $316,000
Q3 2018 Nov 14, 2018	BUY	$6.5 - $8.37 $449,826 - $579,237	69,204 New	69,204 $450,000
Q2 2018 Aug 14, 2018	SELL	$7.27 - $21.88 $224,490 - $675,632	-30,879 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$13.4 - $28.4 $413,778 - $876,963	30,879 New	30,879 $690,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.